The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech; Takeda
Consulting or Advisory Role - AstraZeneca Spain; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Roche/Genentech; Takeda
Research Funding - AstraZeneca Spain (Inst)
GALLANT-1: Galectin-3 (Gal-3) inhibitor GB1211 plus atezolizumab (atezo) in patients with non–small cell lung cancer (NSCLC)—A randomized, double-blind trial.
 
François Ghiringhelli
Honoraria - roche
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Roche/Genentech; Roche/Genentech
 
Ludovic Doucet
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Takeda
Travel, Accommodations, Expenses - Takeda
 
Patricia Barre
No Relationships to Disclose
 
Eric Pichon
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Roche; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Takeda
 
Santiago Ponce Aix
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck; Roche
Travel, Accommodations, Expenses - AstraZeneca; Merck; Roche
 
Oscar Juan-Vidal
No Relationships to Disclose
 
Enric Carcereny
Consulting or Advisory Role - AstraZeneca Spain; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche/Genentech; Takeda
Speakers' Bureau - AstraZeneca Spain; BMSi; MSD Oncology; Roche; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche; Takeda
 
Tariq Sethi
Employment - Galecto
Stock and Other Ownership Interests - AstraZeneca; Galecto
Consulting or Advisory Role - Affibody; Galecto
Research Funding - Galecto
Patents, Royalties, Other Intellectual Property - Galecto
Expert Testimony - Galecto
Travel, Accommodations, Expenses - Galecto
 
Bertil Lindmark
Employment - Galecto
Leadership - ALK; Galecto
Stock and Other Ownership Interests - ALK
 
Alison MacKinnon
Employment - Galecto
Stock and Other Ownership Interests - Galecto
Research Funding - Galecto
Patents, Royalties, Other Intellectual Property - Galecto
Travel, Accommodations, Expenses - Galecto
 
Vassilios Aslanis
Employment - Galecto; Ipsen
Stock and Other Ownership Interests - Galecto; Ipsen
Research Funding - Galecto; Ipsen
Travel, Accommodations, Expenses - Galecto; Ipsen
 
Zahir Rajiwate
Employment - Galecto; Pharmaceutical Research Associates
Stock and Other Ownership Interests - Galecto
Research Funding - Galecto
Travel, Accommodations, Expenses - Galecto
 
Linda Basse
Employment - Galecto